Most patients with diabetic retinopathy who take the GLP-1 agonist semaglutide don t experience a worsening of the condition, a new study found, but they still require screening and follow-up.
THURSDAY, Nov. 9, 2023 (HealthDay News) For patients with type 2 diabetes mellitus, most eyes have no worsening of diabetic retinopathy (DR) after initiation of semaglutide, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Nov. 3 to 6 in San Francisco. Zeeshan Haq, M.D., from
Popular Weight Loss Drug Does Not Appear to Worsen
Diabetic Eye Disease in Most Patients, New Study Suggests. Reseachers address growing concern over vision loss in people taking semaglutide